[1]
Kulvinder Kochar Kaur, MD, Gautam Allahbadia, MD, DNB, and Mandeep Singh, MD, DM, “Improved Management of Type 2 Diabetes Mellitus with Empigliflozin and Hypertension with Renin-Angiotensin System Inhibitors and Manidipine, Preferentially of Dihydropyridones to Optimize Cardiovascular Outcomes”, OR, pp. 1–13, Jan. 2025.